Cite
Baidal DA, Sanchez J, Alejandro R, et al. POSEIDON study: a pilot, safety and feasibility trial of high-dose omega3 fatty acids and high-dose cholecalciferol supplementation in type 1 diabetes. CellR4 Repair Replace Regen Reprogram. 2018;6(1)
Baidal, D. A., Sanchez, J., Alejandro, R., Blaschke, C. E., Hirani, K., Matheson, D. L., Messinger, S., Pugliese, A., Rafkin, L. E., Roque, L. A., Vera Ortiz, J. M., & Ricordi, C. (2018). POSEIDON study: a pilot, safety and feasibility trial of high-dose omega3 fatty acids and high-dose cholecalciferol supplementation in type 1 diabetes. CellR4-- repair, replacement, regeneration, & reprogramming, 6(1), .
Baidal, D A, et al. "POSEIDON study: a pilot, safety and feasibility trial of high-dose omega3 fatty acids and high-dose cholecalciferol supplementation in type 1 diabetes." CellR4-- repair, replacement, regeneration, & reprogramming vol. 6,1 (2018).
Baidal DA, Sanchez J, Alejandro R, Blaschke CE, Hirani K, Matheson DL, Messinger S, Pugliese A, Rafkin LE, Roque LA, Vera Ortiz JM, Ricordi C. POSEIDON study: a pilot, safety and feasibility trial of high-dose omega3 fatty acids and high-dose cholecalciferol supplementation in type 1 diabetes. CellR4 Repair Replace Regen Reprogram. 2018;6(1). Epub 2018 Mar 19. PMID: 33834083; PMCID: PMC8025938.
Copy
Download .nbib